These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 28784776)

  • 1. Stress-inducible gene
    Chang YS; Jalgaonkar SP; Middleton JD; Hai T
    Proc Natl Acad Sci U S A; 2017 Aug; 114(34):E7159-E7168. PubMed ID: 28784776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stress-Inducible Gene
    Middleton JD; Fehlman J; Sivakumar S; Stover DG; Hai T
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xiao-Ai-Ping Injection Enhances Effect of Paclitaxel to Suppress Breast Cancer Proliferation and Metastasis via Activating Transcription Factor 3.
    Chen J; Zhang X; Xiao X; Ding Y; Zhang W; Shi M; Yang J; Liu Y; Han Y
    Integr Cancer Ther; 2020; 19():1534735420906463. PubMed ID: 32248718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcription factor ATF3 links host adaptive response to breast cancer metastasis.
    Wolford CC; McConoughey SJ; Jalgaonkar SP; Leon M; Merchant AS; Dominick JL; Yin X; Chang Y; Zmuda EJ; O'Toole SA; Millar EK; Roller SL; Shapiro CL; Ostrowski MC; Sutherland RL; Hai T
    J Clin Invest; 2013 Jul; 123(7):2893-906. PubMed ID: 23921126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy-Exacerbated Breast Cancer Metastasis: A Paradox Explainable by Dysregulated Adaptive-Response.
    Middleton JD; Stover DG; Hai T
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30373101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NDRG1 Downregulates ATF3 and Inhibits Cisplatin-Induced Cytotoxicity in Lung Cancer A549 Cells.
    Du A; Jiang Y; Fan C
    Int J Med Sci; 2018; 15(13):1502-1507. PubMed ID: 30443171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenylate kinase-4 is a marker of poor clinical outcomes that promotes metastasis of lung cancer by downregulating the transcription factor ATF3.
    Jan YH; Tsai HY; Yang CJ; Huang MS; Yang YF; Lai TC; Lee CH; Jeng YM; Huang CY; Su JL; Chuang YJ; Hsiao M
    Cancer Res; 2012 Oct; 72(19):5119-29. PubMed ID: 23002211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATF3 suppresses metastasis of bladder cancer by regulating gelsolin-mediated remodeling of the actin cytoskeleton.
    Yuan X; Yu L; Li J; Xie G; Rong T; Zhang L; Chen J; Meng Q; Irving AT; Wang D; Williams ED; Liu JP; Sadler AJ; Williams BR; Shen L; Xu D
    Cancer Res; 2013 Jun; 73(12):3625-37. PubMed ID: 23536558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of Activating Transcription Factor 3 Is Associated with Cisplatin Responsiveness in Non-Small Cell Lung Carcinoma Cells.
    Bar J; Hasim MS; Baghai T; Niknejad N; Perkins TJ; Stewart DJ; Sekhon HS; Villeneuve PJ; Dimitroulakos J
    Neoplasia; 2016 Sep; 18(9):525-35. PubMed ID: 27659012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lovastatin-induced apoptosis is mediated by activating transcription factor 3 and enhanced in combination with salubrinal.
    Niknejad N; Gorn-Hondermann I; Ma L; Zahr S; Johnson-Obeseki S; Corsten M; Dimitroulakos J
    Int J Cancer; 2014 Jan; 134(2):268-79. PubMed ID: 23824972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T Cells Promote Metastasis by Regulating Extracellular Matrix Remodeling following Chemotherapy.
    Haj-Shomaly J; Vorontsova A; Barenholz-Cohen T; Levi-Galibov O; Devarasetty M; Timaner M; Raviv Z; Cooper TJ; Soker S; Hasson P; Weihs D; Scherz-Shouval R; Shaked Y
    Cancer Res; 2022 Jan; 82(2):278-291. PubMed ID: 34666995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of activating transcription factor 3 and its interacting proteins under physiological and pathological conditions.
    Rohini M; Haritha Menon A; Selvamurugan N
    Int J Biol Macromol; 2018 Dec; 120(Pt A):310-317. PubMed ID: 30144543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin prevents breast cancer metastasis through blocking early EMT and retards cancer growth together with paclitaxel.
    Wang H; Guo S; Kim SJ; Shao F; Ho JWK; Wong KU; Miao Z; Hao D; Zhao M; Xu J; Zeng J; Wong KH; Di L; Wong AH; Xu X; Deng CX
    Theranostics; 2021; 11(5):2442-2459. PubMed ID: 33500735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activating transcription factor 3-mediated chemo-intervention with cancer chemokines in a noncanonical pathway under endoplasmic reticulum stress.
    Park SH; Kim J; Do KH; Park J; Oh CG; Choi HJ; Song BG; Lee SJ; Kim YS; Moon Y
    J Biol Chem; 2014 Sep; 289(39):27118-27133. PubMed ID: 25122760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATF3, an adaptive-response gene, enhances TGF{beta} signaling and cancer-initiating cell features in breast cancer cells.
    Yin X; Wolford CC; Chang YS; McConoughey SJ; Ramsey SA; Aderem A; Hai T
    J Cell Sci; 2010 Oct; 123(Pt 20):3558-65. PubMed ID: 20930144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activating transcription factor-3 (ATF3) functions as a tumor suppressor in colon cancer and is up-regulated upon heat-shock protein 90 (Hsp90) inhibition.
    Hackl C; Lang SA; Moser C; Mori A; Fichtner-Feigl S; Hellerbrand C; Dietmeier W; Schlitt HJ; Geissler EK; Stoeltzing O
    BMC Cancer; 2010 Dec; 10():668. PubMed ID: 21129190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KAI1 gene is engaged in NDRG1 gene-mediated metastasis suppression through the ATF3-NFkappaB complex in human prostate cancer.
    Liu W; Iiizumi-Gairani M; Okuda H; Kobayashi A; Watabe M; Pai SK; Pandey PR; Xing F; Fukuda K; Modur V; Hirota S; Suzuki K; Chiba T; Endo M; Sugai T; Watabe K
    J Biol Chem; 2011 May; 286(21):18949-59. PubMed ID: 21454613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neovasculature and circulating tumor cells dual-targeting nanoparticles for the treatment of the highly-invasive breast cancer.
    Yao J; Feng J; Gao X; Wei D; Kang T; Zhu Q; Jiang T; Wei X; Chen J
    Biomaterials; 2017 Jan; 113():1-17. PubMed ID: 27794222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tumor metastasis suppressor gene Drg-1 down-regulates the expression of activating transcription factor 3 in prostate cancer.
    Bandyopadhyay S; Wang Y; Zhan R; Pai SK; Watabe M; Iiizumi M; Furuta E; Mohinta S; Liu W; Hirota S; Hosobe S; Tsukada T; Miura K; Takano Y; Saito K; Commes T; Piquemal D; Hai T; Watabe K
    Cancer Res; 2006 Dec; 66(24):11983-90. PubMed ID: 17178897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The activating transcription factor 3 protein suppresses the oncogenic function of mutant p53 proteins.
    Wei S; Wang H; Lu C; Malmut S; Zhang J; Ren S; Yu G; Wang W; Tang DD; Yan C
    J Biol Chem; 2014 Mar; 289(13):8947-59. PubMed ID: 24554706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.